Meanwhile, the X-linked inhibitor of apoptosis protein (XIAP) is associated with cancer progression and cisplatin sensitivity [23,24], whereas XIAP was previously indicated to modulate chemoresistance in NSCLC [25]. This evidence concerns the gene XIAP and non-small cell lung carcinoma.